MIT Academics Market Discovery

BOSTON—Two MIT professors without business experience hope to turn a unique manufacturing process into a commercial success in the burgeoning field of high-temperature superconductivity. Gregory J. Yurek and John Vandersande, both of MIT’s Department of Materials Science and Engineering, decided to launch the American Superconductor Corp. last spring after developing a proprietary process for fabricating superconductors through oxidation of metallic components. The program is sai

Written byDennis Livingston
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

BOSTON—Two MIT professors without business experience hope to turn a unique manufacturing process into a commercial success in the burgeoning field of high-temperature superconductivity.

Gregory J. Yurek and John Vandersande, both of MIT’s Department of Materials Science and Engineering, decided to launch the American Superconductor Corp. last spring after developing a proprietary process for fabricating superconductors through oxidation of metallic components. The program is said to result in superconductors stable at temperatures above 90° K.

“Our final product can be stronger, more flexible and less porous than materials that can be obtained from conventional ceramic processes,” Yurek said. “Superconductors derived from metallic precursors are also easier to cast into useful shapes, such as wire coils, ribbons and windings.”

Seeking help in transferring their idea from the lab to the marketplace, the researchers contacted John Preston, director of MIT’s Technology Licensing Office, who helped them apply for a patent (not yet ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies